Top Markets
Coin of the day
CRISM Therapeutics Corporation CRISM Therapeutics Corporation

CRISM Therapeutics Corporation

CRTX
Rangering i aksjer #40953
CRISM Therapeutics Corporation is dedicated to developing innovative drug... CRISM Therapeutics Corporation is dedicated to developing innovative drug delivery systems that enhance the effectiveness of cancer medications targeting solid tumors. Their primary offering, ChemoSeed, is designed for direct insertion into a tumor or the surgical site post-tumor removal, ensuring that therapeutic concentrations of chemotherapy agents are precisely localized to the cancerous tissue. This technology finds particular application in treating gliomas, a form of brain tumor. The company was established in 2016 and is headquartered in Road Town, British Virgin Islands.
Aksjekurs
$0.15137669
Markedsverdi
$58.28K
Endring (1 dag)
11.25%
Endring (1 år)
6.17%
Land
VG
Handel CRISM Therapeutics Corporation (CRTX)

Kategori

P/B-forhold for CRISM Therapeutics Corporation (CRTX)
P/B-forhold per 2026 TTM: 0
Ifølge CRISM Therapeutics Corporation sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/B-forhold (TTM) 0. Ved slutten av 2026 hadde selskapet et P/B-forhold på 0.
P/B-historikk for CRISM Therapeutics Corporation fra 2026 til 2026
P/B-forhold ved hvert års slutt
År P/B-forhold Endre
Ikke nok data for de angitte datoene.
P/B-forhold for lignende selskaper eller konkurrenter
Selskap P/B-forhold Forskjell i P/B-forhold Land
6.2613 -
US
6.3483 -
NL
- -
CH
- -
KR
3.634 -
BE